Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.73M Sell
6,290
-81
-1% -$22.9K 0.03% 341
2026
Q1
$1.7M Sell
6,371
-164
-3% -$45.4K 0.04% 278
2025
Q4
$1.8M Buy
6,535
+3,961
+154% +$1.11M 0.04% 291
2025
Q3
$742K Buy
2,574
+616
+31% +$182K 0.03% 365
2025
Q2
$647K Sell
1,958
-200
-9% -$64.5K 0.02% 335
2025
Q1
$710K Buy
2,158
+1,299
+151% +$391K 0.06% 212
2024
Q4
$237K Sell
859
-140
-14% -$44.6K 0.05% 194
2024
Q3
$346K Sell
999
-59
-6% -$20.3K 0.08% 146
2024
Q2
$350K Buy
+1,058
New +$365K 0.08% 134

Other funds holding CI

AlphaCore Capital's CI Position: Q2 2026 in Review

AlphaCore Capital reduced its Cigna (CI) stake by 1.3% in Q2 2026, selling an estimated $22.9K and leaving 6,290 shares worth $1.73M. The position accounts for 0.03% of the portfolio, ranked #341.

AlphaCore Capital first reported a position in CI in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.8M in Q4 2025. 1,702 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • AlphaCore Capital held 6,290 shares of Cigna worth $1.73M as of Q2 2026.
  • AlphaCore Capital sold 81 Cigna shares in Q2 2026, an estimated $22.9K.
  • Cigna made up 0.03% of AlphaCore Capital's portfolio in Q2 2026, its #341 holding.
  • AlphaCore Capital first reported a position in Cigna in Q2 2024 and has held it in 9 quarters since.
  • AlphaCore Capital's Cigna position peaked at $1.8M in Q4 2025.
  • 1,702 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.